Critical Unit Economics Checklist for Pre-Revenue Health Tech Startups

Calculating the true cost of acquiring a provider or patient, factoring in sales cycles for enterprise sales to hospital systems or marketing to consumers. This metric must account for longer conversion times typical in healthcare compared to standard SaaS models.

Estimating the total revenue expected from a single patient or provider account over their relationship with the platform. Must include realistic churn assumptions based on clinical outcomes, regulatory changes, or competitor entry in the specific therapeutic area.

Determining the volume of claims or subscriptions required to cover fixed operational costs before achieving profitability. This analysis is critical for startups relying on CPT codes or value-based care contracts where payment latency can impact cash flow.

Measuring the time and effort required for physicians to integrate the solution into their existing EHR workflows. High friction leads to low engagement and eventual churn, so startups must track adoption velocity as a proxy for future retention.

Tracking the percentage of patients who continue using the digital therapy or monitoring tool beyond the initial onboarding phase. Low adherence often indicates poor user experience or lack of clinical necessity, directly impacting long-term unit economics.

Distributing the fixed costs of HIPAA, GDPR, and FDA clearance across expected user volumes to determine per-unit compliance burden. Startups must ensure that these mandatory overheads do not negate margins before any revenue is generated.

Assessing the current status of relevant CPT, HCPCS, or ICD-10 codes that allow providers to bill for the service. Lack of clear reimbursement pathways significantly increases CAC and reduces LTV, making the unit economics unsustainable for most models.

Factoring in the substantial legal and operational expenses associated with negotiating contracts with insurance payers and group purchasers. These indirect costs often exceed direct marketing spend and must be amortized over the contract's duration.

Budgeting for the studies and data collection required to prove medical efficacy, which is often a prerequisite for reimbursement. These upfront R&D expenses impact the initial unit economics and must be accounted for in early financial models.

Estimating the monthly or annual revenue generated per active user, considering tiered pricing structures or subscription fees. Accurate ARPU models help determine if the current pricing strategy aligns with the cost of service delivery and customer support.

Calculating the cost of providing technical and clinical support to users during the critical onboarding phase. Healthcare solutions often require higher touch support than standard apps, which can erode margins if not properly priced in.

Projecting how much revenue is retained from existing customers after accounting for churn, downgrades, and expansions. High NRR is a strong indicator of product-market fit and can offset high initial acquisition costs in early-stage valuations.

Modeling the delay between initial engagement and actual payment receipt, particularly for B2B sales to large health systems. Long sales cycles require additional working capital, which affects the effective cost of capital and overall unit profitability.

Accounting for the technical expenses of building HL7/FHIR integrations with major Electronic Health Record (EHR) systems. These development and maintenance costs are often overlooked in early financial models but significantly impact unit economics.

Analyzing if patient health outcomes correlate with platform usage, allowing for proactive retention strategies. Understanding this link helps reduce involuntary churn and stabilizes the LTV calculation by identifying at-risk users early.

Segmenting projected revenue by payer type (Medicare, Medicaid, Private Insurance) due to varying reimbursement rates. A diverse payer mix reduces risk, but accurate unit economics require modeling the weighted average reimbursement per service delivered.

Determining how marginal costs change as user volume increases, specifically for cloud infrastructure and clinical staff. Health tech often has high variable costs related to care coordination, which must be analyzed to find the optimal scale point.

Setting minimum profitability and growth targets required to satisfy early-stage investors given the high risk in health tech. This external pressure often dictates the aggressive revenue assumptions that must be stress-tested in the unit economics model.

Estimating the realistic percentage of the TAM that can be captured given clinical barriers and reimbursement constraints. Overestimating penetration leads to inflated LTV and unrealistic growth projections, which is a common pitfall in health tech financials.

Quantifying the billable hours of nurses or doctors required to manage the digital intervention for each patient. If the solution does not free up provider time or justify its cost through improved outcomes, the unit economics will fail.